Orthobond
David L. Nichols, CEO

ORTHOBOND™ is a material science company that has developed OSTAGUARD™, an antibacterial surface treatment for medical implants. OSTAGUARD™ antibacterial surface treatment is the first of its kind to be granted U.S. Food and Drug Administration (FDA) De Novo classification. With an initial application in the field of orthopedic spinal implants, OSTAGUARD actively kills the bacteria that contaminate the surfaces of medical devices.

orthobond.com